@cencalwife wrote "Not to be a Debbie Downer, but I've read that Pluvicto studies show an average 4mos. increase in live expectancy. I'm aware could be more, but do the benefits outweigh the risks?"

I'm sorry for everything you're both going through, especially the ADT side-effects.

I just want to add one note that may or may not help (I may also have mentioned this in a comment earlier in the thread replying to someone else).

Usually an average number like "4 months" is a median, not a mean. In other words, half of Pluvicto patients had less than a 4-month increase, and half had more. So you're right that it could be more, but for some in the fortunate half, it could be a *lot* more; with patients who were still alive at the end of the study, they don't know how much extra time Pluvicto will give them.

Best of luck with the next treatment steps, whatever the two of you choose.